27403678|t|Polysaccharide - Specific Memory B Cells Predict Protection against Experimental Human Pneumococcal Carriage
27403678|a|We have previously demonstrated that experimental pneumococcal carriage enhances immunity and protects healthy adults against carriage reacquisition after rechallenge with a homologous strain. To investigate the role of naturally acquired pneumococcal protein and polysaccharide (PS)- specific immunity in protection against carriage acquisition using a heterologous challenge model. We identified healthy volunteers that were naturally colonized with pneumococcus and, after clearance of their natural carriage episode, challenged them with a heterologous 6B strain. In another cohort of volunteers we assessed 6BPS - specific, PspA - specific, and PspC - specific IgG and IgA plasma and memory B-cell populations before and 7, 14, and 35 days after experimental pneumococcal inoculation. Heterologous challenge with 6B resulted in 50% carriage among volunteers with previous natural pneumococcal carriage. Protection from carriage was associated with a high number of circulating 6BPS IgG - secreting memory B cells at baseline. There were no associations between protection from carriage and baseline levels of 6BPS IgG in serum or nasal wash, PspA - specific, or PspC - specific memory B cells or plasma cells. In volunteers who did not develop carriage, the number of circulating 6BPS memory B cells decreased and the number of 6BPS plasma cells increased postinoculation. Our data indicate that naturally acquired PS - specific memory B cells, but not levels of circulating IgG at time of pneumococcal exposure, are associated with protection against carriage acquisition.
27403678	0	14	Polysaccharide	T109,T129	C0032595
27403678	17	25	Specific	T080	C0205369
27403678	26	40	Memory B Cells	T025	C0682638
27403678	49	59	Protection	T033	C1545588
27403678	68	80	Experimental	T080	C1517586
27403678	81	86	Human	T016	C0086418
27403678	87	99	Pneumococcal	T007	C0038410
27403678	100	108	Carriage	T033	C0853960
27403678	117	127	previously	T079	C0205156
27403678	146	158	experimental	T080	C1517586
27403678	159	171	pneumococcal	T007	C0038410
27403678	172	180	carriage	T033	C0853960
27403678	181	189	enhances	T052	C2349975
27403678	190	198	immunity	T039	C0020964
27403678	203	211	protects	T033	C1545588
27403678	212	219	healthy	T080	C3898900
27403678	220	226	adults	T100	C0001675
27403678	227	234	against	T080	C0521124
27403678	235	243	carriage	T033	C0853960
27403678	244	257	reacquisition	T052	C1706701
27403678	264	275	rechallenge	T061	C2347900
27403678	283	293	homologous	T032	C0301883
27403678	294	300	strain	T001	C1518614
27403678	329	338	naturally	T169	C0205296
27403678	339	347	acquired	T080	C0439661
27403678	348	368	pneumococcal protein	T116,T123	C0004627
27403678	373	387	polysaccharide	T109,T129	C0032595
27403678	389	391	PS	T109,T129	C0032595
27403678	394	402	specific	T080	C0205369
27403678	403	411	immunity	T039	C0020964
27403678	415	425	protection	T033	C1545588
27403678	426	433	against	T080	C0521124
27403678	434	442	carriage	T033	C0853960
27403678	443	454	acquisition	T052	C1706701
27403678	463	485	heterologous challenge	T039	C3658217
27403678	507	525	healthy volunteers	T098	C1708335
27403678	536	545	naturally	T169	C0205296
27403678	546	555	colonized	T025	C1947989
27403678	561	573	pneumococcus	T007	C0038410
27403678	585	594	clearance	T080	C0449297
27403678	604	611	natural	T169	C0205296
27403678	612	620	carriage	T033	C0853960
27403678	621	628	episode	T079	C0332189
27403678	653	665	heterologous	T032	C0301884
27403678	666	675	6B strain	T007	C1688613
27403678	688	694	cohort	T098	C0599755
27403678	698	708	volunteers	T098	C1708335
27403678	721	725	6BPS	T109,T129	C0032595
27403678	728	736	specific	T080	C0205369
27403678	738	742	PspA	T116,T129	C0071312
27403678	745	753	specific	T080	C0205369
27403678	759	763	PspC	T116,T129	C2000489
27403678	766	774	specific	T080	C0205369
27403678	775	778	IgG	T116,T121,T129	C0020852
27403678	783	786	IgA	T116,T129	C0020835
27403678	787	793	plasma	T025	C0032112
27403678	798	823	memory B-cell populations	T025	C0682638
27403678	824	830	before	T079	C0332152
27403678	854	859	after	T079	C0687676
27403678	860	872	experimental	T080	C1517586
27403678	873	885	pneumococcal	T007	C0038410
27403678	886	897	inoculation	T061	C2987620
27403678	899	921	Heterologous challenge	T039	C3658217
27403678	927	929	6B	T007	C1688613
27403678	946	954	carriage	T033	C0853960
27403678	961	971	volunteers	T098	C1708335
27403678	977	985	previous	T079	C0205156
27403678	986	993	natural	T169	C0205296
27403678	994	1006	pneumococcal	T007	C0038410
27403678	1007	1015	carriage	T033	C0853960
27403678	1017	1027	Protection	T033	C1545588
27403678	1033	1041	carriage	T033	C0853960
27403678	1046	1061	associated with	T080	C0332281
27403678	1064	1068	high	T080	C0205250
27403678	1079	1090	circulating	T169	C0175630
27403678	1091	1095	6BPS	T109,T129	C0032595
27403678	1096	1099	IgG	T116,T121,T129	C0020852
27403678	1102	1111	secreting	T043	C1327616
27403678	1112	1126	memory B cells	T025	C0682638
27403678	1130	1138	baseline	T081	C1442488
27403678	1154	1166	associations	T080	C0439849
27403678	1175	1185	protection	T033	C1545588
27403678	1191	1199	carriage	T033	C0853960
27403678	1204	1212	baseline	T081	C1442488
27403678	1213	1219	levels	T080	C0441889
27403678	1223	1227	6BPS	T109,T129	C0032595
27403678	1228	1231	IgG	T116,T121,T129	C0020852
27403678	1235	1240	serum	T031	C0229671
27403678	1244	1254	nasal wash	T031	C0206289
27403678	1256	1260	PspA	T116,T129	C0071312
27403678	1263	1271	specific	T080	C0205369
27403678	1276	1280	PspC	T116,T129	C2000489
27403678	1283	1291	specific	T080	C0205369
27403678	1292	1306	memory B cells	T025	C0682638
27403678	1310	1322	plasma cells	T025	C0032112
27403678	1327	1337	volunteers	T098	C1708335
27403678	1346	1357	not develop	T033	C0243095
27403678	1358	1366	carriage	T033	C0853960
27403678	1382	1393	circulating	T169	C0175630
27403678	1394	1398	6BPS	T109,T129	C0032595
27403678	1399	1413	memory B cells	T025	C0682638
27403678	1414	1423	decreased	T081	C0205216
27403678	1442	1446	6BPS	T109,T129	C0032595
27403678	1447	1459	plasma cells	T025	C0032112
27403678	1460	1469	increased	T081	C0205217
27403678	1470	1485	postinoculation	T033	C0231291
27403678	1510	1519	naturally	T169	C0205296
27403678	1520	1528	acquired	T080	C0439661
27403678	1529	1531	PS	T109,T129	C0032595
27403678	1534	1542	specific	T080	C0205369
27403678	1543	1557	memory B cells	T025	C0682638
27403678	1563	1573	not levels	T033	C0243095
27403678	1577	1588	circulating	T169	C0175630
27403678	1589	1592	IgG	T116,T121,T129	C0020852
27403678	1604	1616	pneumococcal	T007	C0038410
27403678	1617	1625	exposure	T080	C0332157
27403678	1631	1646	associated with	T080	C0332281
27403678	1647	1657	protection	T033	C1545588
27403678	1658	1665	against	T080	C0521124
27403678	1666	1674	carriage	T033	C0853960
27403678	1675	1686	acquisition	T052	C1706701